SSShana D. Stites

Shana D. Stites

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shana D. Stites has a total of 260 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lifestyle interventions on Alzheimer's disease and related dementias: Social and structural determinants of implementation effectiveness and sustainability

    by Ganga S. Bey, Sheina Emrani, Erin R. Kulick, Cristina A. F. Román, Ileana De Anda‐Duran, Miriam T. Ashford, Rory Boyle, Omonigho Michael Bubu, Jasmine Dixon, Sanne Franzen, et al.

    Alzheimer's disease and related dementias (ADRD) pose a global public health challenge, and epidemiological evidence underscores profound disparities in ADRD risk and outcomes that are rooted in social/structural determinants of health (S/SDOH). Yet, these determinants are seldom integrated into intervention design or implementation strategies. In this review, we identify S/SDOH that influence the equitable implementation of evidence‐based ADRD lifestyle interventions across diverse groups and explore implications. Guided by Bronfenbrenner's ecological model, we: (1) examined theoretical foundations, focusing on how macrosystem and microsystem factors modulate implementation effectiveness across multiple intervention modalities; (2) synthesized empirical literature, highlighting successful and suboptimal intervention outcomes in marginalized populations; (3) identified critical gaps, especially where evidence on implementation across socially defined groups is lacking; and (4) discussed implications for enhancing design and policy for equitable ADRD intervention delivery. Our goal is to produce a conceptual and empirical synthesis that offers actionable guidance for clinicians, researchers, and policy makers.

  • Open Access

    A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias

    by Mark A. Dubbelman, Tanisha G. Hill-Jarrett, Silvia Chapman, Gustavo Alves Andrade dos Santos, Martina Azar, Ganesh M. Babulal, Tyler R. Bell, Mark A. Bernard, Carolina Boza-Calvo, Anthony Q. Briggs, et al.

    Subjective cognitive decline (SCD) refers to cognitive concerns that may occur with or without objective impairment on standardized testing. Studies suggest that SCD may be an early clinical marker of Alzheimer's disease and related dementias, and that it can predict future objective cognitive decline and progression to dementia. However, the research that supports these conclusions is primarily based on samples with homogeneous socioeconomic and cultural backgrounds. The limited studies in samples with more diverse representations of racial, ethnic, gender, and sexual orientation characteristics show varying SCD prevalence, correlates, and outcomes. Here, we review this literature, focusing on how to apply the findings to advance our understanding of SCD. We further evaluate how our findings inform a roadmap for future research. Overall, we conclude that broader investigations across more diverse populations enhance our understanding of the factors that may differentially contribute to SCD and shape its utility as a clinical metric.

  • Open Access

    Worry and Anxiety in the Era of Early Diagnosis and Disease Modifying Treatment for Alzheimer’s Disease

    by Shana D. Stites, Katherine Lee, Carolyn Kuz, David Mandell, Hillary R. Bogner, Rebecca Brown

    Purpose of Review: Psychologists and psychiatrists are well-positioned to be at the forefront of addressing the challenges posed by anxiety in early diagnosis and treatment of Alzheimer’s disease (AD) dementia that are unfolding in primary care settings. The present article provides a summary of emerging areas in Alzheimer’s disease testing and research to guide clinical decisions and research pursuits. Recent Findings: The present article provides an overview of how anxiety is understood in early diagnosis of dementia due to AD, its influence in AD-related mechanisms, and the implications of these findings on current research practices. Summary: We conducted focused literature reviews between January and June 2026 and synthesized the information to provide a narrative review. Overall, the clinical roles of anxiety in AD dementia are expanding— from being viewed primarily as reactions to cognitive decline to serving as informative features of the diagnostic process and clinical course of the disease.

  • Depression and anxiety modify cognitive concerns associated with amyloid and early clinical impairment.

    by Shana D. Stites, Alzheimer’S Disease Neuroimaging Initiative, Rosalie Schumann, Yidan Shi, Dawn Mechanic-Hamilton, David A. Wolk

    Cognitive concerns (CCs) are common for patients with Alzheimer's disease (AD) dementia. We explore anxiety, depression, and clinical impairment as moderators of CCs in early AD. Understanding these associations may help inform efforts to advance early identification of disease progression in AD. Data sources, selected based on requirements for availability of biomarker data and clinical assessment data, generated a pooled sample of adults ages 65+ with known amyloid status and cognitive function ranging from unimpaired (Clinical Dementia Rating global score [CDR-GS] = 0, n = 5,498) to early impairment (CDR-GS = 0.5, n = 504). Measures of CCs, anxiety, and depression were standardized to cognitively unimpaired groups. To model the difference in effects for different levels of anxiety and depression, we used mixed-effects quantile regression for median adjusted for age, sex, race, and educational years. All reported findings are p < .05. Higher CCs were associated with early clinical impairment (estimated change in median [β] = 15.5). CCs were higher with higher versus lower anxiety, except in unimpaired persons with elevated amyloid. In this latter group of unimpaired persons with elevated amyloid, CCs were higher with higher versus lower depression. In combination elevated amyloid, anxiety, and depression may offer data to guide clinical interpretation of CCs in early clinical impairment. The findings advance understanding of mood effects in early AD and inform specific measurement considerations. Future longitudinal studies are needed. (PsycInfo Database Record (c) 2026 APA, all rights reserved).


  • Open Access

    Four Common Beliefs About Patient Memory Evaluations: Who Has Them and What Modifies Them?

    by Shana D. Stites, Carolyn Kuz, Emily A. Largent, Kristin Harkins, Abba Krieger, Pamela Sankar, Sarah J. Barber

    Understanding public beliefs about patients at memory centers may inform efforts to promote early diagnosis and guide clinical discussions of Alzheimer’s disease (AD). Adults (N=3,527) read a vignette describing a fictional person at a memory center and rated the person’s condition as a mental illness, part of typical aging, and psychological or biological origins. Vignettes varied by AD biomarker result, symptom stage, and treatment availability. Participants most strongly believed that the condition was part of typical aging and biological in origin, though beliefs varied across subgroups. Black and Asian participants reported stronger beliefs than White participants that the condition was a mental illness ( β =0.39, P β =0.46, P β =0.19, P β =0.14, P P =0.04). Biomarker positivity heightened biological and lowered psychological attributions (all P <0.05). The findings offer specific insights to guide intervention.


  • Open Access

    Repeated Administration of Social and Structural Determinants of Health (SSDOH) Questions in an Alzheimer’s Disease Research Center: The Aging Brain Study (ABC) Life Experience Survey

    by Shana D. Stites, Daniel S. Lee, Carolyn Kuz, Valerie Humphreys, Marissa L. Streitz, Sharon X. Xie, Jason Flatt, Crystal M. Glover, Dawn Mechanic-Hamilton

    Social and structural determinants of health (SSDOH) must be measured longitudinally to understand how lived experiences shape trajectories of Alzheimer’s disease and related dementias (ADRD). This study evaluated the feasibility of administering an SSDOH survey to cognitively unimpaired older adults, examining response consistency, changes over time, and missing data patterns. A follow-up survey was conducted with participants in the UPenn Alzheimer’s Disease Research Center clinical cohort an average of 1.7 years after the initial survey. The 225-item questionnaire covered domains including education, social networks, and stressors. At follow-up, markers of feasibility included a 60% completion rate (81 of 135 participants), high item completion (>93%), and minimal missing data (<3% missed more than 10% of data). Logistic regression identified gender, social network size, and social readjustment experiences as predictors of nonrandom missingness. Response changes between administrations were likely due to ambiguity in item phrasing, instructions, or changes in participants’ experiences. Overall, repeated administration of the SSDOH survey was feasible. The response rate was reasonable but lower than expected for a volunteer research sample, suggesting multiple modes of completion may increase engagement. Repeated administration also helped identify ambiguous items and methods for improving the validity and reliability of SSDOH measures.

  • Predictors of extreme future time perspective change in persons who learn an Alzheimer’s disease biomarker test result

    by Shana D. Stites, Mehek Dedhia, Carolyn Kuz

    Future time perspective (FTP) refers to a person’s perceptions of the future as either limited or open-ended (Carstensen, 2006; Carstensen et al., 1999; Lang & Carstensen, 2002). Individual differe...


  • Open Access

    Effects of caregiving experience on expectations of becoming an Alzheimer’s disease caregiver in the future

    by Shana D Stites, Carolyn Kuz, Kristin Harkins, Pamela Sankar, Norma B Coe, Mary Mittelman

    Objectives: Research often focuses on persons who are or have been caregivers to a person with dementia. Little is known about stigma reactions in persons who expect to care for a person with Alzheimer’s disease (AD). Understanding these beliefs may help guide clinical discussions with family members of persons with AD, particularly those diagnosed in the early stages. Methods: A sample of 3,527 adults was randomized to read a vignette describing a fictional person with either a positive or a negative AD biomarker test result. Bivariate and multivariable analyses examined associations between AD caregiver status (expected and experienced) and responses on a modified Family Stigma in Alzheimer’s Disease Scale (FS-ADS). Results: About 31% (n = 1,090) of participants expected to be a caregiver for a person with AD, and most (63%) had previously been a caregiver. Controlling for differences in caregiving experience and other potential confounders, participants expecting (vs. not) to be AD caregivers reported higher willingness to support, more pity, and fewer negative aesthetic attributions than participants with (vs. without) AD caregiving experience (all p < .05). Discussion: Caregiving experience is a strong predictor of a person’s expectations of becoming one in the future, which runs counter to observed caregiving patterns, suggesting that for most people, becoming a caregiver is unexpected. Helping individuals set more accurate expectations for future caregiving roles is essential to support planning and preparation. Specific findings may inform the content of support and education programs that could accompany disclosure of AD biomarkers and early diagnosis.

  • Open Access

    A Cross-Sectional Analysis of Change in Church Activity with Cognitive, Functional, and Mental Health Among Black and White Older Adults

    by Katherine C. Britt, Fanghong Dong, Jill B. Hamilton, Lauren Massimo, Nancy Hodgson, Dawn Mechanic-Hamilton, Shana D. Stites

    Introduction. Stable religious participation may have beneficial contributions to cognitive and mental health; however, less is known about how changes in religious participation, such as disengagement or increased engagement in church activities, affect these health outcomes and whether there are differences between racial groups. This study aimed to examine the association between changes in church activity and cognitive, functional, and mental health in older adults, and explore differences by race. Methods. Using data from the University of Pennsylvania Alzheimer’s Disease Research Center Aging Brain Cohort in 2021-2022, we examined associations between self-reported change in church activity with cognitive and functional health (Global Clinical Dementia Score (CDR) and total CDR) and neuropsychiatric symptoms (Neuropsychiatric Inventory) in cognitively normal older adults (n=158). We used multivariable regression analysis, controlling for self-reported age, sex, education, and social interaction, to examine differences between individuals who identified as either Black or White. Results. Controlling for covariates, Black participants who reported substantially more or less church activity in the last year had lower cognition and function (Global CDR, β = 0.19, 95%CI [0.04, 0.34], p<0.05) and Total CDR (β = 0.30, 95% CI [0.01, 0.58], p = 0.042), and more neuropsychiatric symptoms (β = 0.63, 95% CI [0.02, 1.24], p<0.045). No significance was found in White older adults. Black older adults reporting major changes in church activity experienced lower cognitive, functional, and mental health. Conclusion. To explore if church activity changes could be an early sign of cognitive, functional, and mental health decline, longitudinal studies are needed.

  • Open Access

    Parental Influence: Childhood caregiver well‐being associates with epigenetic aging among older adults

    by Shana D. Stites, Morgann Adams, Carolyn Kuz, Kimberly Halberstadter, Valerie Humphreys, Corey T. McMillan, Dawn Mechanic‐Hamilton

    Background: A parent's well‐being is instrumental for the child's safety, health and enrichment and these factors are all known to contribute to poorer late‐life health outcomes. Epigenetic age, measured using DNA methylation, represents a biological feature of aging that reflects the extent to which an individual is accelerated or decelerated relative to their chronological age. Here we evaluate how parental relationship type and well‐being associate with later life epigenetic age. Method: Cognitively unimpaired older (>65 years) adults ( N = 152) completed the Penn Alzheimer's Disease Research Center's Life Experience Survey. Questions inquired about relationship type (i.e., mother, father, aunt etc.) and overall well‐being of up to three childhood caregivers. Ratings were from 0‐100 with higher being better. Participants also completed measures of socioeconomic status and sociodemographic data. DNA methylation was measured using genomic blood and the Illumina EPIC array to compute Horvath and Levine epigenetic clocks. Linear regression models examined effects of parental relationship type and parental well‐being ratings on age acceleration in bivariate models, which permitted examination of single parents and types of dyads (i.e., mother‐father, mother‐grandmother) and trivariate models, which allowed each parent relationship type to covary independently. Multivariable models controlled for potential confounding from socioeconomic status, adverse childhood events, and key demographic factors. Results: Father relationship type showed a statistical trend toward decelerated aging (Horvath, β=3.5, 95%CI ‐0.02 to 7.0). In bivariate models, better parental well‐being was associated with decelerated aging (Levin, β=0.14, 95%CI 0.02, 0.24). Secondary parent well‐being showed no effect. In trivariate models, better primary parent well‐being was associated with decelerated aging (Levin, β=0.14, 95%CI 0.02, 0.24; Horvath, β=0.09, 95%CI 0.03, 0.10). Secondary parent well‐being higher than the primary parent's was associated with accelerated aging (Levin, β=‐0.08, 95%CI ‐0.2 to 0.02, p = 0.05; Horvath, β=‐0.09, 95%CI ‐0.1, ‐0.03). These associations remained in multivariable models. Conclusion: Our findings provide evidence for protective and negative biological aging outcomes associated with primary compared to secondary parental well‐being. Thus, it is important to consider social context on aging outcomes. The findings underscore the import of caregivers in the health of older adults. This research line may inform population‐level health interventions.